Teva's generic label not skinny enough to protect from $234M damages to GSK - MedCity News
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel
Teva Pharmaceuticals Found Liable in Landmark Opioid Trial - The New York Times
/cloudfront-us-east-2.images.arcpublishing.com/reuters/QWY4KJXSNVKQZH4U3JFZHKO74Q.jpg "Teva must face government's kickback claims over Copaxone - judge | Reuters")
Teva must face government's kickback claims over Copaxone - judge | Reuters
Generic Drug Lawsuit Could Mean Big Fines for Teva, Mylan: UBS
Teva Stock Pressured From Antitrust Lawsuit Against Drug Makers | Barron's
Teva boss hits out at opioid lawsuits | Financial Times
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
Teva at the center of a lawsuit for raising drug prices - The Jerusalem Post
Attorney General Morrisey sues opioid makers Johnson & Johnson, Teva Pharmaceuticals | WBOY.com
Trouble at Teva: US price-fixing lawsuit adds to generic giant's woes - Pharma Technology Focus | Issue 85 | August 2019
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
Teva Pharmaceuticals - Wikipedia
Teva settles opioid lawsuit with Oklahoma for $85 million - MarketWatch
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Teva Stock Climbs as CEO Says Opioid Settlement Could Come Within a Year | Barron's
Teva's Recovery Hopes Mired in Staggering Antitrust Lawsuit, $26.7 Billion Debt | The Jewish Press - JewishPress.com | David Israel | 7 Iyyar 5779 – May 12, 2019 | JewishPress.com
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
Teva Pharmaceuticals Faces FCA Lawsuit Over Illegal Kickbacks, Company Stocks Drop by 10%
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
